Mesothelioma Empowerment

A 1976 study headed by researchers at Mt. Sinai tested 20 consumer talc products for the presence of asbestos. Ten of the twenty products tested were found to contain asbestos in concentrations from 2-20%. ( "Asbestos Found in Ten Powders, New York Times, March 10, 1976 ): Products containing ...
For the first time ever, doctors and patients have collaborated in the effort to improve our litigation system, improve cancer research, and focus the attention on the unique damages that mesothelioma patients must endure. The 10 page policy paper is authored by The Doctor-Patient Alliance for ...
Coping with cancer and its aftermath both physically and emotionally is a challenging process that taxes all those involved, including the ones at risk and their loved ones. However, don't let the financial burdens unduly increase stress. There are many sources for financial assistance, which ...
How much faith should we put in published, peer reviewed studies which show that a drug, vitamin, surgical technique or medical device produces a favorable result? We certainly want to believe that a conclusion based on raw data generated in a properly designed test by objective scientists must be ...
Mesothelioma is expensive. Not only does the cancer itself exact a heavy toll on the patient, it can also blow apart his or her savings. To live longer, patients need to be prepared to pay more. Mesothelioma patients who are fortunate enough to be eligible for multi-modal therapies must fork over ...
Lives Claimed: Deaths from 1965-1999 due to asbestos exposure: 259,000. --This number represents approximately 4,000 deaths per year. --Starting in 1965: the number of deaths increases by 400-500 a year. -- By the mid-1900s: approximately 9,700 deaths per year. Why the steady increase? ...
Award Damages Commensurate with Costs, Compensate Swiftly and Increase Medical Research Funding: Comments on SB 852 We are concerned citizens, an alliance of doctors and patients, brought together by our mission to defeat mesothelioma as a life-ending disease. We are intimately familiar with the ...
It is for me an honor to introduce the IMIG conference. Summarizing the whole story of mesothelioma in fifteen minutes is a difficult challenge, so, I will focus on different aspects and questions relating to causal factors. In 1992, Christ Wagner opened the Paris conference focusing on the early ...
In early 2008, our firm wrote an article laying out the choices and difficulties faced by newly diagnosed mesothelioma patients. We suggested that patients need more data and more hard information from surgeons and oncologists regarding options. We also laid out the differences in reported survival ...
Speakers from all over the world came to the University of Pennsylvania campus to share research and ideas on how to fight back against a common enemy: malignant mesothelioma ( MM ). Topics included biology, genetics, immunology, carcinogenesis, epidemiology, pathology, gene therapy, clinical ...